PATENT CLAIM ANALYSIS

Application Number: 16041067
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "449000"]

Abstract:
Methods and devices are provided for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye of a human subject for the treatment of a posterior ocular disorder or a choroidal malady. In one embodiment, the method comprises inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles.

Claim (Index 11):
The composition of  claim 1 , further comprising sodium acetate.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.84746
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15673073', '15086485', '15001610', '13453407', '13447246']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7815488882698512
- 35 USC 102 Novelty (BERT): 0.5928974274720014
- Combined Prediction Score: 0.7626837421900663
- Mean Citation Score: 523.442268
- Max Citation Score: 703.27563
- Similarity Product: 402.6326691230034

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test